AirSculpt Technologies Announces Leadership Changes
09 Agosto 2024 - 5:00AM
AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the
“Company”), a national provider of premium body contouring
procedures, today announced Todd Magazine has stepped down from his
role as Chief Executive Officer and as a member of the Board of
Directors of the Company. Mr. Magazine will serve as an advisor to
the Company through December 31, 2024. Dennis Dean, Chief Financial
Officer has assumed the position of interim Chief Executive Officer
until a permanent successor is named.
Dr. Aaron Rollins, Executive Chairman of the Board stated: “I am
confident in our business model and see tremendous opportunity to
expand upon our Company’s competitive strengths and proprietary
technology to enable AirSculpt to achieve a higher level of growth
in the future. I am also pleased to announce that Dennis Dean,
Chief Financial Officer has assumed the position of Interim CEO
while we conduct a search for a permanent successor. Dennis is the
right choice for this position as we focus on our core body
contouring procedures, remove long-term oriented marketing spend
and increase fiscal discipline as we navigate a dynamic economic
environment. I want to thank Todd for his leadership and
contributions over the past 18 months and look forward to
continuing to benefit from his insight as an advisor.”
Dennis Dean, stated: “I am honored to assume an interim CEO role
and excited about our long-term potential. In the near term, we
will execute our plan to focus on our core operations and reduce
expenses so that we are positioned to scale more efficiently and
return to the delivery of consistent revenue growth at industry
leading EBITDA margins as the external environment improves.”
Todd Magazine stated, “It has been rewarding to work alongside
the Board and the entire AirSculpt team. I am a big believer in
AirSculpt with its unique procedures that help our patients to lead
happier, healthier and more productive lives. Over the next few
months my top priority is to ensure a smooth transition. I look
forward to seeing the Company achieve its goals in the coming
years.”
About AirSculpt
AirSculpt is a next-generation body contouring treatment
designed to optimize both comfort and precision, available
exclusively at AirSculpt offices. The minimally invasive procedure
removes fat and tightens skin, while sculpting targeted areas of
the body, allowing for quick healing with minimal bruising, tighter
skin, and precise results.
To learn more about AirSculpt Technologies, please visit the
Company's website at https://investors.elitebodysculpture.com.
AirSculpt Technologies uses its website as a channel of
distribution for material Company information. Financial and other
material information regarding AirSculpt Technologies is routinely
posted on the Company's website and is readily accessible.
Forward-Looking Statements
This press release contains forward-looking statements. In some
cases, you can identify these statements by forward-looking words
such as “may,” “might,” “will,” “should,” “expects,” “plans,”
“anticipates,” “believes,” “estimates,” “predicts,” “potential” or
“continue,” the negative of these terms and other comparable
terminology, but the absence of these words does not mean that a
statement is not forward-looking. These forward-looking statements,
which are subject to risks, uncertainties, and assumptions about
us, may include projections of our future financial performance,
our anticipated growth strategies, and anticipated trends in our
business. These statements are only predictions based on our
current expectations and projections about future events. You are
cautioned that there are important risks and uncertainties, many of
which are beyond our control, that could cause our actual results,
level of activity, performance, or achievements to differ
materially from the projected results, level of activity,
performance or achievements that are expressed or implied by such
forward-looking statements. We qualify all of our forward-looking
statements by these cautionary statements, including those factors
discussed in the section titled “Risk Factors” in our Annual Report
on Form 10-K.
Our future results could be affected by a variety of other
factors, including, but not limited to, failure to open and operate
new centers in a timely and cost-effective manner; inability to
open new centers due to rising interest rates and increased
operating expenses due to rising inflation; increased competition
in the weight loss and obesity solutions market, including as a
result of the recent regulatory approval, increased market
acceptance, availability and customer awareness of weight-loss
drugs; shortages or quality control issues with third-party
manufacturers or suppliers; competition for surgeons; litigation or
medical malpractice claims; inability to protect the
confidentiality of our proprietary information; changes in the laws
governing the corporate practice of medicine or fee-splitting;
changes in the regulatory, macroeconomic conditions, including
inflation and the threat of recession, economic and other
conditions of the states and jurisdictions where our facilities are
located; and business disruption or other losses from war,
pandemic, terrorist acts or political unrest.
The risk factors discussed in “Item 1A. Risk Factors” in our
Annual Report on Form 10-K and in other filings we make from time
to time with the U.S. Securities and Exchange Commission could
cause our results to differ materially from those expressed in the
forward-looking statements made in this press release.
There also may be other risks and uncertainties that are
currently unknown to us or that we are unable to predict at this
time.
Although we believe the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee
future results, level of activity, performance, or achievements.
Moreover, neither we nor any other person assumes responsibility
for the accuracy and completeness of any of these forward-looking
statements. Forward-looking statements represent our estimates and
assumptions only as of the date they were made, which are
inherently subject to change, and we are under no duty and we
assume no obligation to update any of these forward-looking
statements, or to update the reasons actual results could differ
materially from those anticipated after the date of this press
release to conform our prior statements to actual results or
revised expectations, except as required by law. Given these
uncertainties, investors should not place undue reliance on these
forward-looking statements.
Investor ContactAllison MalkinICR,
Inc.airsculpt@icrinc.com
AirSculpt Technologies (NASDAQ:AIRS)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
AirSculpt Technologies (NASDAQ:AIRS)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024